pc:draig

Draig Therapeutics

Cardiff, Wales, GB

https://www.draigtherapeutics.com/

Draig Therapeutics is a privately held biotechnology company focused on the discovery and development of novel therapeutic candidates. Publicly available information about the company's specific programs, modalities and organizational details is limited.

Leadership & Board

Current Number of Employees41

Current LinkedIn Followers6,235

Latest Estimated Valuation

Estimated Valuation―

Estimated Valuation―

Total Amount Raised$140M

Total Amount Raised$140M

Total Funding Rounds1

Total Funding Rounds1

Latest Funding Amount$140M

Latest Funding Amount$140M

Latest Funding RoundSeries A

Latest Funding RoundSeries A

Post-Money Valuation―

Post-Money Valuation―

Funding Round

Jul 18, 2025

Series A

$140.00M

―

Investors

Access Biotechnology

Series A

Related News and Analysis

Draig Therapeutics – Weekly Recap

Draig Therapeutics – Weekly Recap

Draig Therapeutics is the focus of this weekly summary of notable developments affecting the company. Draig Therapeutics is...

16h ago

Draig Therapeutics Leadership Featured at U.K. Life Sciences Summit

Draig Therapeutics Leadership Featured at U.K. Life Sciences Summit

According to a recent LinkedIn post from Draig Therapeutics, the company’s CEO Ivana Magovcevic-Liebisch is scheduled to participate...

4d ago

Draig Therapeutics CEO Joins High-Level U.K. Life Sciences Summit

Draig Therapeutics CEO Joins High-Level U.K. Life Sciences Summit

According to a recent LinkedIn post from Draig Therapeutics, the U.K. life sciences sector is portrayed as being...

5d ago

Draig Therapeutics Boosts Clinical and Strategic Visibility With DT-101 Data Preview and C-Suite Networking

Draig Therapeutics Boosts Clinical and Strategic Visibility With DT-101 Data Preview and C-Suite Networking

Draig Therapeutics featured prominently this week with new clinical and investor-facing updates centered on its lead candidate DT-101....

22d ago

Draig Therapeutics to Present Phase 1 Data on DT-101 at Key Psychopharmacology Meeting

Draig Therapeutics to Present Phase 1 Data on DT-101 at Key Psychopharmacology Meeting

According to a recent LinkedIn post from Draig Therapeutics, the company plans to present new data on DT-101...

25d ago

Draig Therapeutics Previews Phase 1 DT-101 Data at Major Psychopharmacology Meeting

Draig Therapeutics Previews Phase 1 DT-101 Data at Major Psychopharmacology Meeting

According to a recent LinkedIn post from Draig Therapeutics, the company is scheduled to present new data from...

25d ago

Draig Therapeutics Highlights Executive Visibility With Convergence Forum C-Suite Participation

Draig Therapeutics Highlights Executive Visibility With Convergence Forum C-Suite Participation

Draig Therapeutics is in the spotlight this week as CEO and President Ivana Magovcevic-Liebisch prepares to join a...

29d ago

Draig Therapeutics Leadership Engages in High-Level Convergence Forum Discussion

Draig Therapeutics Leadership Engages in High-Level Convergence Forum Discussion

According to a recent LinkedIn post from Draig Therapeutics, CEO and President Ivana Magovcevic-Liebisch is scheduled to participate...

1M ago

Draig Therapeutics Leadership Featured at Convergence Forum C-Suite Session

Draig Therapeutics Leadership Featured at Convergence Forum C-Suite Session

According to a recent LinkedIn post from Draig Therapeutics, CEO and President Ivana Magovcevic-Liebisch is scheduled to participate...

1M ago

Community Engagement Around Great Plains Industrial Park Nuclear Project

Community Engagement Around Great Plains Industrial Park Nuclear Project

A LinkedIn post from Deep Fission describes the company’s participation in the Katy Days Festival in Parsons, Kansas,...

2h ago